Skip to main content

Advertisement

SpringerLink
Log in

Relationship between prevalence and risk of osteoporosis or osteoporotic fracture with non-alcoholic fatty liver disease: A systematic review and meta-analysis

  • Review
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

The aim of this study was to investigate the relationship between prevalence and risks of osteoporosis or osteoporotic fracture and NAFLD. Patients with NAFLD should be monitored regularly for bone mineral density and bone metabolism indicators to prevent osteoporosis or osteoporotic fractures.

Objectives

The aim of this meta-analysis was to investigate the relationship between prevalence and risks of osteoporosis or osteoporotic fracture and non-alcoholic fatty liver disease (NAFLD).

Methods

Five databases, including PubMed, Web of Science, Embase, Scopus and Cochrane Library, were searched since the conception of these databases until December 2021. The cohort studies, cross-sectional analyses or case–control studies evaluating the relationship between osteoporosis or osteoporotic fracture and NAFLD were retrieved from these databases. Relevant data were extracted from the included studies, and a meta-analysis was performed.

Results

A total of seven studies were included. The prevalence of osteoporosis or osteoporotic fractures was higher in the NAFLD group than in the non-NAFLD group [OR = 1.17, 95%CI(1.04,1.31)], while the prevalence of osteoporosis was higher in the NAFLD group than in the non-NAFLD group [OR = 1.46, 95%CI (1.21,1.77) and OR = 1.48, 95%CI (1.31,1.68), respectively] in men and women. The risk of osteoporosis or osteoporotic fractures was higher in the NAFLD group than in the non-NAFLD group [OR = 1.33,95%CI (1.24,1.44) and OR = 1.57,95%CI (1.08,2.29), respectively]. The risk of osteoporosis or osteoporotic fractures was higher in male and female NAFLD groups than that in the non-NAFLD group [OR = 1.29, 95%CI(1.14,1.47) and OR = 1.36, 95%CI (1.25,1.48), respectively]. After parameter adjustment, the risk of osteoporosis or osteoporotic fracture was higher in the male NAFLD group than in the non-NAFLD group [OR = 2.10, 95%CI(1.36,3.25)], while no significant difference was found among women [OR = 1.13, 95%CI (0.86,1.48)].

Conclusions

The prevalence and risk of osteoporosis or osteoporotic fractures were significantly associated with NAFLD in men and women.

Trial registration: PROSPERO 2022 CRD42022304708

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Cobbina E, Akhlaghi F (2017)Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters. Drug Metab Rev 49(2):197–211. https://doi.org/10.1080/03602532.2017.1293683

  2. Mundi MS, Velapati S, Patel J, Kellogg TA, Abu Dayyeh BK, Hurt RT (2020) Evolution of NAFLD and Its Management. Nutr Clin Pract 35(1):72–84. https://doi.org/10.1002/ncp.10449

    Article  PubMed  Google Scholar 

  3. Michelotti GA, Machado MV, Diehl AM (2013) NAFLD, NASH and liver cancer. Nat Rev Gastroenterol Hepatol 10(11):656–665. https://doi.org/10.1038/nrgastro.2013.183

    Article  CAS  PubMed  Google Scholar 

  4. Patel N, Sharma B, Samant H (2021) Cryptogenic Cirrhosis. StatPearls Publishing, In StatPearls

    Google Scholar 

  5. Dai G, Liu P, Li X, Zhou X, He S (2019) Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease (NAFLD) susceptibility and severity: A meta-analysis. Medicine 98(7):e14324. https://doi.org/10.1097/MD.0000000000014324

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Hotta K, Yoneda M, Hetal H (2010) Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease. BMC Med Genet 11:172. https://doi.org/10.1186/1471-2350-11-172

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Trépo E, Valenti L (2020) Update on NAFLD genetics: From new variants to the clinic. J Hepatol 72(6):1196–1209. https://doi.org/10.1016/j.jhep.2020.02.020

    Article  CAS  PubMed  Google Scholar 

  8. Carlsson B, Lindén D, Brolén G et al (2020) Review article: the emerging role of genetics in precision medicine for patients with non-alcoholic steatohepatitis. Aliment PharmacolTher 51(12):1305–1320. https://doi.org/10.1111/apt.15738

    Article  CAS  Google Scholar 

  9. Fatty Liver and Alcoholic Liver Disease Group of the Chinese Medical Association, Fatty Liver Disease Expert Committee of the Chinese Medical Association (2018) Guidelines of prevention and treatment for nonalcoholic fatty liver disease:a 2018 update [J].J Pract Hepatol 177–186. https://doi.org/10.3969/j.issn.1672-5069.2018.02.007

  10. Qadir A, Liang S, Zetal Wu (2020) Senile Osteoporosis: The Involvement of Differentiation and Senescence of Bone Marrow Stromal Cells. Int J Mol Sci 21(1):349. https://doi.org/10.3390/ijms21010349

    Article  CAS  PubMed Central  Google Scholar 

  11. Kiernan J, Davies JE, Stanford WL (2017) Concise Review: Musculoskeletal Stem Cells to Treat Age-Related Osteoporosis. Stem Cells Transl Med 6(10):1930–1939. https://doi.org/10.1002/sctm.17-0054

    Article  PubMed  PubMed Central  Google Scholar 

  12. Florencio-Silva R, Sasso GR, Sasso-Cerri E et al (2015) Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells. Biomed Res Int 2015:421746. https://doi.org/10.1155/2015/421746

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Li X, Kordsmeier J, Xiong J (2021) New Advances in Osteocyte Mechanotransduction. CurrOsteoporos Rep 19(1):101–106. https://doi.org/10.1007/s11914-020-00650-y

    Article  Google Scholar 

  14. Clynes MA, Harvey NC, Curtis EM et al (2020) The epidemiology of osteoporosis. Br Med Bull 133(1):105–117. https://doi.org/10.1093/bmb/ldaa005

    Article  PubMed  Google Scholar 

  15. Anam AK, Insogna K (2021) Update on Osteoporosis Screening and Management. Med Clin North Am 105(6):1117–1134. https://doi.org/10.1016/j.mcna.2021.05.016

    Article  PubMed  Google Scholar 

  16. Yang YJ, Kim DJ (2021) An Overview of the Molecular Mechanisms Contributing to Musculoskeletal Disorders in Chronic Liver Disease: Osteoporosis, Sarcopenia, and Osteoporotic Sarcopenia. Int J Mol Sci 22(5):2604. https://doi.org/10.3390/ijms22052604

  17. Locatelli V, Bianchi VE (2014) Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis. Int J Endocrinol 2014:235060. https://doi.org/10.1155/2014/235060

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Mantovani A, Dauriz M, Gatti D et al (2019) Systematic review with meta-analysis: non-alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density. Aliment Pharmacol Ther 49(4):375–388. https://doi.org/10.1111/apt.15087

    Article  PubMed  Google Scholar 

  19. Xie R, Liu M (2022) Relationship Between Non-Alcoholic Fatty Liver Disease and Degree of Hepatic Steatosis and Bone Mineral Density. Front Endocrinol 13:857110. https://doi.org/10.3389/fendo.2022.857110

    Article  Google Scholar 

  20. Shen Z, Cen L, Chen X, Pan J, Li Y, Chen W, Yu C (2020) Increased risk of low bone mineral density in patients with non-alcoholic fatty liver disease: a cohort study. Eur J Endocrinol 182(2):157–164. https://doi.org/10.1530/EJE-19-0699

    Article  CAS  PubMed  Google Scholar 

  21. Upala S, Jaruvongvanich V, Wijarnpreecha K, Sanguankeo A (2017) Nonalcoholic fatty liver disease and osteoporosis: a systematic review and meta-analysis. J Bone Miner Metab 35(6):685–693. https://doi.org/10.1007/s00774-016-0807-2

    Article  CAS  PubMed  Google Scholar 

  22. Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605. https://doi.org/10.1007/s10654-010-9491-z

    Article  PubMed  Google Scholar 

  23. Li M, Xu Y, Metal Xu (2012) Association between nonalcoholic fatty liver disease (NAFLD) and osteoporotic fracture in middle-aged and elderly Chinese. J Clin Endocrinol Metab 97(6):2033–2038. https://doi.org/10.1210/jc.2011-3010

    Article  CAS  PubMed  Google Scholar 

  24. Lee SH, Yun JM, Kim SH et al (2016) Association between bone mineral density and nonalcoholic fatty liver disease in Korean adults. J Endocrinol Invest 39(11):1329–1336. https://doi.org/10.1007/s40618-016-0528-3

    Article  CAS  PubMed  Google Scholar 

  25. Kim G, Kim KJ, Rhee Y, Lim SK (2017) Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease. PLoS ONE 12(7):e0182202. https://doi.org/10.1371/journal.pone.0182202

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Chen HJ, Yang HY, Hsueh KC et al (2018) Increased risk of osteoporosis in patients with nonalcoholic fatty liver disease: A population-based retrospective cohort study. Medicine (Baltimore) 97(42): e12835. https://doi.org/10.1097/MD.0000000000012835

  27. Wang Y, Wen G, Retal Z (2018) Association of Nonalcoholic Fatty Liver Disease With Osteoporotic Fractures: A Cross-Sectional Retrospective Study of Chinese Individuals. Front Endocrinol (Lausanne) 9:408. https://doi.org/10.3389/fendo.2018.00408

    Article  Google Scholar 

  28. Lee HJ, Lee DC, Kim CO (2021) Association Between 10-Year Fracture Probability and Nonalcoholic Fatty Liver Disease With or Without Sarcopenia in Korean Men: A Nationwide Population-Based Cross-Sectional Study. Front Endocrinol (Lausanne) 12:599339. https://doi.org/10.3389/fendo.2021.599339

    Article  Google Scholar 

  29. Loosen SH, Roderburg C, Metal D (2021) Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of osteoporosis and bone fractures. Z Gastroenterol. https://doi.org/10.1055/a-1482-9236.10.1055/a-1482-9236

    Article  PubMed  Google Scholar 

  30. Wáng Y, Lentle BC (2020) Radiographic osteoporotic vertebral fractures in elderly men: a brief review focusing on differences between the sexes. Quant Imaging Med Surg 10(9):1863–1876. https://doi.org/10.21037/qims-2020-21

  31. Wang D, Liu N, Gao Y, Li P, Tian M (2014) Association between metabolic syndrome and osteoporotic fracture in middle-aged and elderly Chinese peoples. Cell Biochem Biophys 70(2):1297–1303. https://doi.org/10.1007/s12013-014-0054-x

  32. Lee J, Yoon K, Ryu S, Chang Y, Kim HR (2017) High-normal levels of hs-CRP predict the development of non-alcoholic fatty liver in healthy men. PLoS ONE 12(2):e0172666. https://doi.org/10.1371/journal.pone.0172666

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Noh JY, Yang Y, Jung H (2020) Molecular Mechanisms and Emerging Therapeutics for Osteoporosis. Int J Mol Sci 21(20):7623. https://doi.org/10.3390/ijms21207623

    Article  CAS  PubMed Central  Google Scholar 

  34. Laurent MR, Dedeyne L, Dupont J, Mellaerts B, Dejaeger M, Gielen E (2019) Age-related bone loss and sarcopenia in men. Maturitas 122:51–56. https://doi.org/10.1016/j.maturitas.2019.01.006

    Article  PubMed  Google Scholar 

  35. Jähn-Rickert K, Zimmermann EA (2021) Potential Role of Perilacunar Remodeling in the Progression of Osteoporosis and Implications on Age-Related Decline in Fracture Resistance of Bone. Curr Osteoporos Rep 19(4):391–402. https://doi.org/10.1007/s11914-021-00686-8

    Article  PubMed  Google Scholar 

  36. Aydın MM, Akçalı KC (2018) Liver fibrosis. Turk J Gastroenterol 29(1):14–21. https://doi.org/10.5152/tjg.2018.17330

    Article  PubMed  PubMed Central  Google Scholar 

  37. Povero D, Feldstein AE (2016) Novel Molecular Mechanisms in the Development of Non-Alcoholic Steatohepatitis. Diabetes Metab J 40(1):1–11. https://doi.org/10.4093/dmj.2016.40.1.1

    Article  PubMed  PubMed Central  Google Scholar 

  38. Yang L, Yang CQ (2021) Liver cirrhosis and secondary osteoporosis. Chin J Hepatol 29(3):204–208. https://doi.org/10.3760/cma.j.cn501113-20210208-00078

    Article  CAS  Google Scholar 

  39. Filip R, Radzki RP, Bieńko M (2018) Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis. Clin Interv Aging 13:1879–1891. https://doi.org/10.2147/CIA.S170533:1879-1891

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Xian L, Wu X, Pang L et al (2012) Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells. Nat Med 18(7):1095–1101. https://doi.org/10.1038/nm.2793

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Wang Y, Dai J, Zhong W, Hu C, Lu S, Chai Y (2018) Association between Serum Cholesterol Level and Osteoporotic Fractures. Front Endocrinol (Lausanne) 9:30. https://doi.org/10.3389/fendo.2018.00030

    Article  Google Scholar 

  42. An T, Hao J, Sun S et al (2017) Efficacy of statins for osteoporosis: a systematic review and meta-analysis. Osteoporos Int 28(1):47–57. https://doi.org/10.1007/s00198-016-3844-8

  43. Zhang Z, Thorne JL, Moore JB (2019) Vitamin D and nonalcoholic fatty liver disease. CurrOpin Clin NutrMetab Care 22(6):449–458. https://doi.org/10.1097/MCO.0000000000000605

    Article  CAS  Google Scholar 

  44. Barchetta I, Cimini FA, Cavallo MG (2017) Vitamin D Supplementation and Non-Alcoholic Fatty Liver Disease: Present and Future. Nutrients 9(9):1015. https://doi.org/10.3390/nu9091015

    Article  CAS  PubMed Central  Google Scholar 

  45. Erem S, Atfi A, Razzaque MS (2019) Anabolic effects of vitamin D and magnesium in aging bone. J Steroid Biochem Mol Biol 193:105400. https://doi.org/10.1016/j.jsbmb.2019.105400

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This study was funded by National Natural Science Foundation of China (No.81960155), Natural Science Foundation of Gansu Province (20JR10RA690) and Health industry scientific research project of Gansu Province (No.GSWSKY-2019–07).

Author information

Authors and Affiliations

  1. The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China

    Binjing Pan, Jing Cai, Pingping Zhao, Jingfang Liu, Songbo Fu, Gaojing Jing, Qianglong Niu & Qiong Li

  2. Department of Endocrinology, The First Hospital of Lan zhou University, Lanzhou, Gansu, China

    Jingfang Liu, Songbo Fu, Gaojing Jing, Qianglong Niu & Qiong Li

Authors
  1. Binjing Pan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jing Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pingping Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jingfang Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Songbo Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gaojing Jing
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Qianglong Niu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Qiong Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jingfang Liu.

Ethics declarations

Data Sharing

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Consent to participate

Not applicable.

Conflicts of interest

Binjing Pan, Jing Cai, Pingping Zhao, Jingfang Liu, Gaojing Jing, QianglongNiu, and Qiong Li declare that they have no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 18 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pan, B., Cai, J., Zhao, P. et al. Relationship between prevalence and risk of osteoporosis or osteoporotic fracture with non-alcoholic fatty liver disease: A systematic review and meta-analysis. Osteoporos Int 33, 2275–2286 (2022). https://doi.org/10.1007/s00198-022-06459-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-022-06459-y

Keywords

Search

Navigation